SCHEMBL13017802

SCHEMBL13017802

CB(O)OO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13893268 0.74
SCHEMBL5839937 0.70
SCHEMBL17996064 0.70
SCHEMBL27629935 0.67 LMNA (0.33)
SCHEMBL7884727 0.67 LMNA (0.33)
SCHEMBL18470 0.67
SCHEMBL8431278 0.67 LMNA (0.33)
SCHEMBL24600809 0.67
SCHEMBL15779028 0.67
Methylamine SCHEMBL9752169 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240215277-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2024-06-27 US disclosed
US-9562186-B2 Oligomeric and polymeric electronically-modified boronic acids and methods of using the same HALLIBURTON ENERGY SERVICES, INC. (US) 2017-02-07 US disclosed
US-20150210918-A1 OLIGOMERIC AND POLYMERIC ELECTRONICALLY-MODIFIED BORONIC ACIDS AND METHODS OF USING THE SAME HALLIBURTON ENERGY SERVICES, INC. (US) 2015-07-30 US disclosed
US-9027644-B2 Oligomeric and polymeric electronically-modified boronic acids and methods of using the same HALLIBURTON ENERGY SERVICES, INC. (US) 2015-05-12 US disclosed
US-20140174748-A1 OLIGOMERIC AND POLYMERIC ELECTRONICALLY-MODIFIED BORONIC ACIDS AND METHODS OF USING THE SAME HALLIBURTON ENERGY SERVICES, INC. (US) 2014-06-26 US disclosed
US-20140110120-A1 Oligomeric and Polymeric Electronically-Modified Boronic Acids and Methods of Using the Same HALLIBURTON ENERGY SERVICES, INC. (US) 2014-04-24 US disclosed
US-7858621-B2 Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same AMOREPACIFIC CORPORATION (KR) 2010-12-28 US disclosed
US-20080312234-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2008-12-18 US disclosed